ClassID:

109145

C12N2310/14 - page 18 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.

Recent Application in this class:
#5101
20160304879
2016-10-20

Double-stranded RNA compounds to CASP2 and uses thereof

#5102
20160304878
2016-10-20

Nucleic acid inducing RNA interference modified for preventing off-target, and use thereof

#5103
20160304875
2016-10-20

METHODS FOR TREATMENT OF WOUND HEALING UTILIZING CHEMICALLY MODIFIED OLIGONUCLEOTIDES

#5104
20160304873
2016-10-20

Immunotherapy of cancer

#5105
20160304870
2016-10-20

Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA

#5106
20160304868
2016-10-20

Compositions of asymmetric interfering RNA and uses thereof

#5107
20160304867
2016-10-20

SiRNA and their use in methods and compositions for inhibiting the expression of the FLAP gene

#5108
20160304866
2016-10-20

Drug for Disease Caused by Expression of Periostin Except Eye Disease, and Use Thereof

#5109
20160304863
2016-10-20

3′end caps for RNAi agents for use in RNA interference

#5110
20160304624
2016-10-20

Cell-based anti-cancer compositions with reduced toxicity and methods of making and using the same

#5111
20160304487
2016-10-20

Cationic lipid

#5112
20160303054
2016-10-20

FORMULATIONS FOR INHIBITION OF pcsk9 FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA

#5113
20160303047
2016-10-20

MEANS FOR LUNG SPECIFIC DELIVERY

#5114
20160298124
2016-10-13

Complement component iRNA compositions and methods of use thereof

#5115
20160298123
2016-10-13

RNA INTERFERENCE MEDIATED INHIBITION OF PROLYL HYDROXYLASE DOMAIN 2 (PHD2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)

#5116
20160298122
2016-10-13

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MYLIP/IDOL GENE

#5117
20160298119
2016-10-13

Pharmaceutical composition for treatment of radiation- or drug-resistant cancer comprising HRP-3 inhibitor

#5118
20160298114
2016-10-13

Haplotype Based Generalizable Allele Specific Silencing for Therapy of Cardiovascular Disease

#5119
20160297860
2016-10-13

IDENTIFICATION OF A NOVEL B CELL CYTOKINE

#5120
20160291016
2016-10-06

Composition comprising a cell sample from a subject with scoliosis and a reagent for detecting PTPμ or PIPK1y

#5121
20160289759
2016-10-06

Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related disease by inhibition of natural antisense transcript to PYCR1

#5122
20160289689
2016-10-06

METHOD FOR TRANSFORMATION OF STRAMENOPILE

#5123
20160289688
2016-10-06

Compositions and methods for use in treating silicosis and lung cancer

#5124
20160289687
2016-10-06

Small interference RNAs, uses thereof and method for inhibiting the expression of PLK1 gene

#5125
20160289686
2016-10-06

Methods for identifying therapeutic targets and treating monitoring cancers

#5126
20160289685
2016-10-06

Method of inhibiting macrophage activation using an inhibitor of PARP9

#5127
20160289684
2016-10-06

Use of IKK epsilon inhibitors to activate NFAT and T cell response

#5128
20160289681
2016-10-06

RNA-BASED HIV INHIBITORS

#5129
20160289676
2016-10-06

Compositions and methods for inhibiting NF-κB and SOD-1 to treat amyotrophic lateral sclerosis

#5130
20160289311
2016-10-06

Compositions and methods for treating cancer by rational targeting of protein translation

#5131
20160281173
2016-09-29

Breast cancer biomarkers and methods of using same

#5132
20160281093
2016-09-29

Methods and compositions for interference with DNA polymerase and DNA synthesis

#5133
20160281088
2016-09-29

Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG

#5134
20160281086
2016-09-29

Quantification and spatio-temporal tracking of a target using a spherical nucleic acid (SNA)

#5135
20160281085
2016-09-29

Molecular targets for selective eradication of senescent cells

#5136
20160281084
2016-09-29

RNA INTERFERENCE SUPPRESSION OF NEURODEGENERATIVE DISEASES AND METHODS OF USE THEREOF

#5137
20160281083
2016-09-29

MODULATION OF TIMP1 AND TIMP2 EXPRESSION

#5138
20160281082
2016-09-29

MAGNETIC INORGANIC IRON-BASED NANOPARTICLES

#5139
20160279256
2016-09-29

Multi-arm biodegradable polymers for nucleic acid delivery

#5140
20160279207
2016-09-29

TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY

#5141
20160279190
2016-09-29

MODULATION OF AXON DEGENERATION

#5142
20160273037
2016-09-22

Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisene transcript to CSF3

#5143
20160272979
2016-09-22

Organic compositions to treat beta-ENaC-related diseases

#5144
20160272978
2016-09-22

Compositions and methods for inhibiting gene expression of factor XII

#5145
20160272976
2016-09-22

PRODUCTS AND METHODS FOR TREATMENT OF FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS

#5146
20160272975
2016-09-22

CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID MOLECULES THAT MEDIATE RNA INTERFERENCE

#5147
20160272972
2016-09-22

METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING COMPONENTS THAT SELF ASSEMBLE IN CELLS AND PRODUCE RNAI ACTIVITY

#5148
20160272971
2016-09-22

Disulfide-containing alkyne linking agents

#5149
20160272970
2016-09-22

RNA Interference Agents

#5150
20160272969
2016-09-22

COMPOSITIONS AND METHODS FOR MODULATING AUTOPHAGIC CELL DEATH

#5151
20160272967
2016-09-22

NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND USES THEREOF

#5152
20160271258
2016-09-22

Dual Peptide-Mediated Targeted Delivery System

#5153
20160271229
2016-09-22

Methods for treating hepatitis C virus infectious disease

#5154
20160271216
2016-09-22

COMPOSITIONS AND METHODS RELATING TO C5L2

#5155
20160264991
2016-09-15

RNA POLYMERASE I1 NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS

#5156
20160264977
2016-09-15

IMPROVED WOUND HEALING COMPOSITIONS AND TREATMENTS

#5157
20160264976
2016-09-15

Dynamin 2 inhibitor for the treatment of centronuclear myopathies

#5158
20160264974
2016-09-15

Use of microRNA precursors as drugs for inducing CD34-positive adult stem cell expansion

#5159
20160264973
2016-09-15

Methods relating to circulating tumor cell clusters and the treatment of cancer

#5160
20160264972
2016-09-15

Compositions and Methods for Inhibiting Expression of a Gene from the Ebola Virus

#5161
20160264971
2016-09-15

COMPOSITIONS AND METHODS FOR SILENCING EBOLA VIRUS GENE EXPRESSION

#5162
20160264968
2016-09-15

MODIFIED iRNA AGENTS

#5163
20160264966
2016-09-15

Compositions and methods for inhibiting expression of the LECT2 gene

#5164
20160264964
2016-09-15

RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)

#5165
20160264963
2016-09-15

Compositions and Methods for Inhibiting Expression of Transthyretin

#5166
20160264933
2016-09-15

CELL DIFFERENTIATION MARKER AND ITS USES

#5167
20160263362
2016-09-15

MICRONEEDLE ARRAYS FOR ACTIVE AGENT DELIVERY

#5168
20160263200
2016-09-15

Compositions and methods for promoting the mineralization of biological tissue

#5169
20160263184
2016-09-15

METHODS OF CONTROLLING VASCULARITY USING RAVER2 AS A MEDIATOR FOR EXPRESSION OF VEGF RECEPTOR SFIT1

#5170
20160258966
2016-09-08

Compositions and Methods for Diagnosing and Treating Diseases and Disorders Associated With D-DT

#5171
20160257969
2016-09-08

Method to trigger RNA interference

#5172
20160257963
2016-09-08

RNAi-MEDIATED INHIBITION OF SPLEEN TYROSINE KINASE-RELATED INFLAMMATORY CONDITIONS

#5173
20160257962
2016-09-08

RNA INTERFERENCE MEDIATED INHIBITION OF ISOCITRATE DEHYDROGENASE (IDH1) GENE EXPRESSION

#5174
20160257961
2016-09-08

POLYNUCLEOTIDE CONSTRUCTS HAVING DISULFIDE GROUPS

#5175
20160257960
2016-09-08

MCPIP protection against osteoclast production

#5176
20160257957
2016-09-08

METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS

#5177
20160257956
2016-09-08

Interfering RNA delivery system and uses thereof

#5178
20160257954
2016-09-08

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#5179
20160257953
2016-09-08

COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET

#5180
20160257951
2016-09-08

Cationic lipid

#5181
20160257735
2016-09-08

REGULATION OF NPVF GENE AND ITS PRODUCTS: A METHOD FOR MODULATING ENERGY IMBALANCE

#5182
20160256570
2016-09-08

Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety

#5183
20160256569
2016-09-08

Block copolymers and uses thereof

#5184
20160256559
2016-09-08

Sterically stabilized cationic nanocarrier, kits and method of use

#5185
20160256524
2016-09-08

Reactivation of Axon Growth and Recovery in Chronic Spinal Cord Injury

#5186
20160251723
2016-09-01

Mutant calreticulin for the diagnosis of myeloid malignancies

#5187
20160251681
2016-09-01

Non-liposomal systems for nucleic acid delivery

#5188
20160251671
2016-09-01

TRANSGENIC TREES HAVING REDUCED XYLAN CONTENT

#5189
20160251662
2016-09-01

COMPOSITIONS AND METHODS FOR TREATING CANCER AND MODULATING STRESS GRANULE FORMATION

#5190
20160251654
2016-09-01

Short hairpin RNA compositions, methods of making and applications thereof

#5191
20160251477
2016-09-01

Poly(amine-co-ester) nanoparticles and methods of use thereof

#5192
20160251446
2016-09-01

PIK3C2G fusions

#5193
20160245816
2016-08-25

Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

#5194
20160244766
2016-08-25

Compositions and methods for inhibiting expression of the ALAS1 gene

#5195
20160244765
2016-08-25

Reduced size self-delivering RNAI compounds

#5196
20160244764
2016-08-25

Methods for predicting the progression and treating a chronic kidney disease in a patient

#5197
20160244763
2016-08-25

Complement component C5 iRNA compositions and methods of use thereof

#5198
20160244761
2016-08-25

Lipid particles with asymmetric cationic lipids for RNA delivery

#5199
20160244760
2016-08-25

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

#5200
20160244756
2016-08-25

Formats for organic compounds for use in RNA interference

#5201
20160244752
2016-08-25

Serpina1 siRNAs: compositions of matter and methods of treatment

#5202
20160244521
2016-08-25

Anti-PVRIG antibodies and methods of use

#5203
20160244517
2016-08-25

Method of inhibiting activation of a T cell by administering an anti-RGM antibody or an RGM siRNA

#5204
20160244492
2016-08-25

HCBI sequences as an early marker for the future development of cancer and diseases of the CNS and as a target for cancer treatment and prevention

#5205
20160243256
2016-08-25

Nucleic acid-lipopolymer compositions

#5206
20160243169
2016-08-25

DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS

#5207
20160237500
2016-08-18

RNY-derived small RNAs as biomarkers for atherosclerosis-related disorders

#5208
20160237440
2016-08-18

siRNA and their use in methods and compositions for inhibiting the expression of the PDK1 gene

#5209
20160237438
2016-08-18

Methods and compositions for the specific inhibition of complement component 5(C5) by double-stranded RNA

#5210
20160237430
2016-08-18

ALLELE-SPECIFIC RNA SILENCING FOR THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY

#5211
20160237429
2016-08-18

Compounds for inducing anti-tumor immunity and methods thereof

#5212
20160237428
2016-08-18

Methods and compositions to inhibit metastasis and to treat fibrosis and to enhance wound healing

#5213
20160237168
2016-08-18

Methods for Treating and Preventing Multiple Sclerosis

#5214
20160235856
2016-08-18

Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types

#5215
20160235675
2016-08-18

Technology for the Preparation of Microparticles

#5216
20160230173
2016-08-11

Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer

#5217
20160230170
2016-08-11

siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAI, and stabilized forms thereof

#5218
20160230169
2016-08-11

RNA INTERFERENCE SUPPRESSION OF NEURODEGENERATIVE DISEASES AND METHODS OF USE THEREOF

#5219
20160229882
2016-08-11

Non-enzymatic, salt-mediated synthesis of polynucleic acids

#5220
20160228567
2016-08-11

Hypoxia-Targeted Delivery System for Pharmaceutical Agents

#5221
20160227787
2016-08-11

Biological control of insects

#5222
20160223567
2016-08-04

METHOD OF TREATING AND PROGNOSING SCOLIOTIC PATIENT SUBGROUPS

#5223
20160222408
2016-08-04

Parental RNAi suppression of chromatin remodeling genes to control coleopteran pests

#5224
20160222407
2016-08-04

PARENTAL RNAI SUPPRESSION OF HUNCHBACK GENE TO CONTROL COLEOPTERAN PESTS

#5225
20160222388
2016-08-04

Inhibition of ferrochelatase as an antiangiogenic therapy

#5226
20160222387
2016-08-04

Anti-tumor therapy

#5227
20160222384
2016-08-04

Compositions for targeted delivery of siRNA

#5228
20160222381
2016-08-04

Single-stranded RNAi agents containing an internal, non-nucleic acid spacer

#5229
20160222131
2016-08-04

ATRX AS A COMPANION DIAGNOSTIC FOR CDK4 INHIBITORS

#5230
20160222128
2016-08-04

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

#5231
20160222072
2016-08-04

Universal protein tag for double stranded nucleic acid delivery

#5232
20160220697
2016-08-04

Cell-specific targeting using nanostructured delivery systems

#5233
20160220599
2016-08-04

NOVEL LINCRNA AND INTERFERING NUCLEIC ACID MOLECULES, COMPOSITIONS AND METHODS AND USES THEREOF FOR REGULATING ANGIOGENESIS AND RELATED CONDITIONS

#5234
20160220532
2016-08-04

Methods and compositions for ameliorating pancreatic cancer

#5235
20160216277
2016-07-28

Kits for classifying a subject having or at risk for developing idiopathic scoliosis

#5236
20160215293
2016-07-28

UNA OLIGOMER ACTIVE STRUCTURES FOR THERAPEUTIC AGENTS

#5237
20160215292
2016-07-28

Notch 1 specific siRNA molecule

#5238
20160215290
2016-07-28

RNAi for the control of phytopathogenic fungi and oomycetes by inhibiting the expression of CYP51 genes

#5239
20160215289
2016-07-28

METHODS OF MODULATING LYMPHANGIOGENESIS, E.G., TO TREAT CORNEAL TRANSPLANT REJECTION, IN A SUBJECT

#5240
20160215288
2016-07-28

Organic compounds to treat hepatitis B virus

#5241
20160215286
2016-07-28

THERAPEUTIC COMPOSITIONS AND METHODS FOR MALIGNANT TUMORS WITH RNAI MOLECULES TARGETED TO HSP47 AND P21

#5242
20160215285
2016-07-28

Methods of modulating compliance of the trabecular meshwork

#5243
20160215284
2016-07-28

Compositions and methods for treating lung disease and injury

#5244
20160215042
2016-07-28

METHODS FOR MODULATING IMMUNE RESPONSES DURING CHRONIC IMMUNE CONDITIONS BY TARGETING METALLOTHIONEINS

#5245
20160213790
2016-07-28

Ph-sensitive peptides and their nanoparticles for drug delivery

#5246
20160213777
2016-07-28

Novel Delivery Compositions and Methods of Using Same

#5247
20160209417
2016-07-21

Methods of diagnosing, classifying and treating endometrial cancer and precancer

#5248
20160208335
2016-07-21

Use of RHOA in cancer diagnosis and inhibitor screening

#5249
20160208280
2016-07-21

Genetic inhibition by double-stranded RNA

#5250
20160208266
2016-07-21

Methods and means for treatment of osteoarthritis

#5251
20160208265
2016-07-21

RNA interference agents for GST-PI gene modulation

#5252
20160208263
2016-07-21

Liposome for topical administration and application thereof

#5253
20160208261
2016-07-21

METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES

#5254
20160208256
2016-07-21

RNA interference agents for P21 gene modulation

#5255
20160208255
2016-07-21

RNA agents for P21 gene modulation

#5256
20160208254
2016-07-21

RNA agents for GST-Pi gene modulation

#5257
20160208253
2016-07-21

PARENTAL RNAI SUPPRESSION OF KRUPPEL GENE TO CONTROL COLEOPTERAN PESTS

#5258
20160208252
2016-07-21

Parental RNAI suppression of hunchback gene to control hemipteran pests

#5259
20160208251
2016-07-21

Parental RNAi suppression of chromatin remodeling genes to control coleopteran pests

#5260
20160208249
2016-07-21

Compositions and Methods for Inducing Senescence in Cancer Cells

#5261
20160208248
2016-07-21

Neurocalcin delta inhibitors and therapeutic and non-therapeutic uses thereof

#5262
20160208247
2016-07-21

METHODS OF USE OF SPHINGOLIPID POLYALKYLAMINE OLIGONUCLEOTIDE COMPOUNDS

#5263
20160208245
2016-07-21

RNA/DNA nanoparticle for siRNA target-specific delivery and vehicle including the same

#5264
20160206750
2016-07-21

Block copolymers

#5265
20160206749
2016-07-21

METHODS AND COMPOSITIONS FOR ENHANCING DELIVERY OF DOUBLE-STRANDED RNA OR A DOUBLE-STRANDED HYBRID NUCLEIC ACID TO REGULATE GENE EXPRESSION IN MAMMALIAN CELLS

#5266
20160206741
2016-07-21

Hydrogels for delivery of therapeutic compounds

#5267
20160206740
2016-07-21

Conjugated lipomers and uses thereof

#5268
20160206739
2016-07-21

Tyrosine-based lipids for delivery of therapeutics

#5269
20160206647
2016-07-21

Nanocomplexes for co-delivering a drug and siRNA and uses thereof

#5270
20160206646
2016-07-21

Bruton's Tyrosine Kinase as Anti-Cancer Drug Target

#5271
20160202269
2016-07-14

Method of treating pain with an antibody against netrin-4, Unc5B or neogenin

#5272
20160201066
2016-07-14

Cytotoxic T cell response modifiers

#5273
20160201065
2016-07-14

Methods and compositions for selecting siRNA of improved functionality

#5274
20160201063
2016-07-14

EPIGENETIC REGULATORS OF FRATAXIN

#5275
20160201061
2016-07-14

Antisense-based small RNA agents targeting the Gag open reading frame of HIV-1 RNA

#5276
20160201058
2016-07-14

Methods and compositions for selecting siRNA of improved functionality

#5277
20160201057
2016-07-14

SPARC (secreted protein, acidic and rich in cysteine), a new target for the treatment and prevention of acute liver failure

#5278
20160200804
2016-07-14

COMPOSITIONS AND METHODS FOR TREATING ANAPLASTIC THYROID CANCER

#5279
20160199504
2016-07-14

Development of novel macromolecule transduction domain with improved cell permeability and method for using same

#5280
20160199485
2016-07-14

Lipids and compositions for the delivery of therapeutics

#5281
20160199419
2016-07-14

Biomolecular group related to cell anti-aging

#5282
20160199403
2016-07-14

Methods and Compositions for Inducing Deregulation of EPHA7 and ERK Phosphorylation in Human Acute Leukemias

#5283
20160199402
2016-07-14

Methods for treating ischemia-reperfusion injury

#5284
20160199386
2016-07-14

Methods of treating thyroid eye disease

#5285
20160194658
2016-07-07

NUCAMPHOLIN NUCLEIC ACID MOLECULES TO CONTROL COLEOPTERAN INSECT PESTS

#5286
20160194646
2016-07-07

Methods and compositions for selecting siRNA of improved functionality

#5287
20160194645
2016-07-07

Compositions and methods for inhibiting expression of mutant EGFR gene

#5288
20160194644
2016-07-07

Ligase E3 RNF185 inhibitors and uses thereof

#5289
20160194643
2016-07-07

Methods of identifying and treating poor prognosis cancers

#5290
20160194642
2016-07-07

SPHERICAL NUCLEIC ACID-BASED CONSTRUCTS AS IMMUNOREGULATORY AGENTS

#5291
20160194640
2016-07-07

DESIGN AND CONSTRUCTION OF BIFUNCTIONAL SHORT HAIRPIN RNA

#5292
20160194639
2016-07-07

INHIBITING CANCER METASTASIS

#5293
20160194634
2016-07-07

Methods for treating and/or limiting development of diabetes

#5294
20160194633
2016-07-07

Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene

#5295
20160194632
2016-07-07

Targeting non-coding RNA for RNA interference

#5296
20160194631
2016-07-07

Methods for Modulation of Autophagy Through the Modulation of Autophagy-Inhibiting Gene Products

#5297
20160194613
2016-07-07

Compositions and methods for inhibiting gene expressions

#5298
20160194403
2016-07-07

Modulation of γδ T cells

#5299
20160193362
2016-07-07

NEW CELL-SPECIFICALLY ACTIVE NUCLEOTIDE MOLECULES AND APPLICATION KIT FOR THE APPLICATION THEREOF

#5300
20160193355
2016-07-07

Novel linker, preparation method, and application thereof

#5301
20160193354
2016-07-07

Antisense oligonucleotides with improved pharmacokinetic properties

#5302
20160193331
2016-07-07

Methods for treating and/or limiting development of diabetes

#5303
20160193242
2016-07-07

Methods and compositions for selecting siRNA of improved functionality

#5304
20160186209
2016-06-30

RECOMBINANT CELLS AND METHODS OF USING SUCH CELLS TO IDENTIFY CIRCADIAN RHYTHM MODULATORS

#5305
20160186185
2016-06-30

Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

#5306
20160186183
2016-06-30

Methods and compositions for treating malignant tumors associated with KRAS mutation

#5307
20160186182
2016-06-30

RNA interference compositions and methods for malignant tumors

#5308
20160186181
2016-06-30

Composition for reducing senescence of cell or subject comprising smurf2 inhibitor and use thereof

#5309
20160186180
2016-06-30

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#5310
20160186179
2016-06-30

Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro

#5311
20160186176
2016-06-30

Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA

#5312
20160186172
2016-06-30

Compositions and methods for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression

#5313
20160186170
2016-06-30

Compositions and methods for induced tissue regeneration in mammalian species

#5314
20160185873
2016-06-30

Monoclonal anti-GT 468 antibodies for treatment of cancer

#5315
20160185872
2016-06-30

COMPOSITIONS AND METHODS FOR TREATING BONE CONDITIONS

#5316
20160185845
2016-06-30

METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE

#5317
20160185843
2016-06-30

Treating alcohol-mediated disorders by inhibition of RGS6

#5318
20160185834
2016-06-30

Protein engineered systems for delivery of molecules

#5319
20160184449
2016-06-30

PEPTIDE-AND AMINE-MODIFIED GLUCAN PARTICLES FOR DELIVERY OF THERAPEUTIC CARGOES

#5320
20160184443
2016-06-30

PLGA-modified polyethylenimine self-assembly nanotechnology for nucleic acid and drug delivery

#5321
20160177389
2016-06-23

FUS/TLS-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases

#5322
20160177315
2016-06-23

Fidgetin-like 2 as a target to enhance wound healing

#5323
20160177314
2016-06-23

Organic small hairpin RNAs

#5324
20160177313
2016-06-23

Compositions and methods for increasing erythropoietin (EPO) production

#5325
20160177310
2016-06-23

Conserved HBV and HCV sequences useful for gene silencing

#5326
20160177303
2016-06-23

Methods and compositions for the specific inhibition of HIF-1α by double-stranded RNA

#5327
20160177302
2016-06-23

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

#5328
20160177299
2016-06-23

Compositions and methods using capsids resistant to hydrolases

#5329
20160177296
2016-06-23

E. COLI MEDIATED siRNA SILENCING OF AVIAN INFLUENZA IN CHICKENS

#5330
20160176967
2016-06-23

Methods and materials for treating cancer

#5331
20160176936
2016-06-23

MPS peptides and use thereof

#5332
20160176903
2016-06-23

System for delivering therapeutic agents into living cells and cells nuclei

#5333
20160175456
2016-06-23

Peptide sequence design and use thereof for peptide-mediated siRNA delivery

#5334
20160175452
2016-06-23

Sphingolipid-polyalkylamine-oligonucleotide compounds

#5335
20160175446
2016-06-23

AGENT FOR TREATING FIBROSIS OF THE INTESTINE

#5336
20160175434
2016-06-23

Methods of treating pre-eclampsia or eclampsia

#5337
20160175339
2016-06-23

METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TUMORIGENICITY

#5338
20160168573
2016-06-16

LIVER CANCER RELATED GENES-SPECIFIC siRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE siRNA, AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME

#5339
20160168572
2016-06-16

Delivery of therapeutic agent

#5340
20160168568
2016-06-16

Treatment of Adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an Adiponectin (ADIPOQ)

#5341
20160168567
2016-06-16

UNA single stranded oligomers for therapeutics

#5342
20160168565
2016-06-16

Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids

#5343
20160168245
2016-06-16

TRPM4 channel inhibitors for stroke treatment

#5344
20160166532
2016-06-16

CARNITINE PALMITOYLTRANSFERASE 1 INHIBITORS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS

#5345
20160161494
2016-06-09

Methods and compositions for treating and diagnosing diseases

#5346
20160161470
2016-06-09

Modulation of axon degeneration

#5347
20160160220
2016-06-09

Methods and compositions for treating autoimmune disorders by targeting Kv1.3 ion channels with functionalized lipid-derived nanovesicles

#5348
20160160219
2016-06-09

Methods for suppressing adipocyte differentiation

#5349
20160160215
2016-06-09

Polynucleotides for multivalent RNA interference, compositions and methods of use thereof

#5350
20160160213
2016-06-09

METHODS OF TREATING CANCER AND PREVENTING CANCER DRUG RESISTANCE

#5351
20160160212
2016-06-09

Compositions and methods for regulating gene expression via RNA interference

#5352
20160160201
2016-06-09

Polypeptides having cellobiohydrolase activity and polynucleotides encoding same

#5353
20160160186
2016-06-09

Therapeutic phages and methods for delivery of nucleic acids for therapeutic uses

#5354
20160159927
2016-06-09

Identification of VSIG8 as the putative VISTA receptor (V-R) and use thereof to produce VISTA/VSIG8 agonists and antagonists

#5355
20160159889
2016-06-09

Inhibition of the synthesis of beta-app or the activity of the A-β peptide in the choroid plexus

#5356
20160158381
2016-06-09

NOVEL NANOLIPOSOMES AND THEIR USE FOR THE TREATMENT OF AMYLOID PROTEIN DISEASES

#5357
20160158363
2016-06-09

Multi-tailed lipids and uses thereof

#5358
20160158210
2016-06-09

Corneal endothelium ECM therapeutic medicaments

#5359
20160153976
2016-06-02

Polyarginine-coated magnetic nanovector and methods of use thereof

#5360
20160153002
2016-06-02

METHOD FOR CELL MEMBRANE PERMEATION FOR COMPOUND

#5361
20160152988
2016-06-02

Compositions and methods for efficacious and safe delivery of siRNA using specific chitosan-based nanocomplexes

#5362
20160152987
2016-06-02

Compositions and methods for controlled delivery of inhibitory ribonucleic acids

#5363
20160152985
2016-06-02

Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitor

#5364
20160152980
2016-06-02

Method of regulating gene expression

#5365
20160152979
2016-06-02

NOVEL COMPOUNDS

#5366
20160152978
2016-06-02

Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes

#5367
20160152976
2016-06-02

COMPOUND ADMINISTRATION PRECURSOR AND MEDICAMENT CARRIER PREPARATION

#5368
20160152975
2016-06-02

METHOD FOR RECOMBINANT PROTEIN PRODUCTION IN MAMMALIAN CELLS

#5369
20160152973
2016-06-02

Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference

#5370
20160152961
2016-06-02

Polypeptides Having Endoglucanase Activity And Polynucleotides Encoding Same

#5371
20160151514
2016-06-02

Low density lipoprotein receptor-mediated siRNA delivery

#5372
20160151407
2016-06-02

Compositions and methods for treating alzheimer's disease and other tauopathies

#5373
20160151404
2016-06-02

Nucleic acid particles, methods and use thereof

#5374
20160145692
2016-05-26

Methods and compositions involving lincRNA and leukemia

#5375
20160145629
2016-05-26

TMPRSS6 iRNA compositions and methods of use thereof

#5376
20160145627
2016-05-26

RNA interference-based therapeutic against anthrax

#5377
20160145626
2016-05-26

Compositions and methods for inhibiting expression of TMPRSS6 gene

#5378
20160145624
2016-05-26

LIVER CANCER RELATED GENES-SPECIFIC siRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE siRNA, AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME

#5379
20160145623
2016-05-26

METHOD FOR THE TARGETED KILLING OF CELLS BY NUCLEOTIDE MOLECULES THAT ARE DIRECTED TO mRNA BINDING, AND ALSO NUCLEOTIDE MOLECULES AND APPLICATION KIT FOR SUCH USE

#5380
20160145622
2016-05-26

Dengue virus-specific siRNA, double helix oligo-RNA structure comprising siRNA, and composition for suppressing proliferation of dengue virus comprising RNA structure

#5381
20160145621
2016-05-26

RNAi agent for inhibition of Chikungunya virus

#5382
20160145613
2016-05-26

Oligonucleotide duplexes comprising DNA-like and RNA-like nucleotides and uses thereof

#5383
20160145611
2016-05-26

Age-related macular degeneration treatment

#5384
20160145610
2016-05-26

Compositions and methods for the delivery of nucleic acids

#5385
20160144057
2016-05-26

Methods for expressing a polynucleotide of interest in the retina of a subject

#5386
20160143995
2016-05-26

Method of treating intracellular infection

#5387
20160143951
2016-05-26

Dosage compensating transgenes and cells

#5388
20160143917
2016-05-26

COMPOSITIONS AND METHODS FOR MODULATING HIV ACTIVATION

#5389
20160139149
2016-05-19

CHI3L1 FOR THE DETECTION AND TREATMENT OF NONALCOHOLIC STEATOHEPATITIS

#5390
20160139127
2016-05-19

Oncogene associated with human cancers and methods of use thereof

#5391
20160139120
2016-05-19

RAGE AS A C1Q RECEPTOR, METHODS AND APPLICATIONS

#5392
20160138044
2016-05-19

Compositions and methods for delivering nucleic acid to a cell

#5393
20160138028
2016-05-19

Glucan-encapsulated siRNA for treating type 2 diabetes mellitus

#5394
20160138027
2016-05-19

TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH DYSREGULATION OF MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1 (MTORC1)

#5395
20160138026
2016-05-19

COMPOSITIONS AND METHODS FOR THE TREATMENT OF VprBP-RELATED CANCERS

#5396
20160138024
2016-05-19

Screening Method For Compound Having Obesity Preventive Or Therapeutic Activity

#5397
20160138021
2016-05-19

Compositions and methods for treating cancer and other diseases

#5398
20160138008
2016-05-19

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#5399
20160136297
2016-05-19

Targeting ABCB5 for cancer therapy

#5400
20160130663
2016-05-12

METHOD FOR PREDICTING RESPONSE TO CANCER TREATMENT